Navigation Links
TGen Physician-In-Chief Dr. Daniel D. Von Hoff wins ASCO award
Date:4/1/2010

PHOENIX, Ariz. April 1, 2010 Dr. Daniel D. Von Hoff, Physician-in-Chief for the Translational Genomics Research Institute (TGen), has won a top award from the American Society of Clinical Oncology (ASCO) for his cancer research.

Dr. Von Hoff, M.D., F.A.C.P., will receive the 2010 David A. Karnofsky Memorial Award and Lecture at ASCO's 46th Annual Meeting, June 4-8 at the McCormick Place in Chicago.

ASCO will present the award to Dr. Von Hoff "for his outstanding achievements in cancer research and for his impact on the treatment of patients with cancer."

Dr. Von Hoff is an internationally recognized physician-scientist who has contributed to the development of numerous anticancer agents, including paclitaxel, docetaxel, irinotecan and gemcitabine. He also is the Chief Scientific Officer of TGen Clinical Research Services at Scottsdale Healthcare and at US Oncology, and is a Clinical Professor of Medicine at the University of Arizona College of Medicine.

Each year through its Special Awards Program, ASCO recognizes quality researchers, patient advocates and leaders of the global oncology community who through their work have made significant contributions to enhancing cancer care. These recipients of ASCO's highest, most prestigious awards collectively represent significant strides in cancer treatment and leadership in the oncology community.

"The work of this year's awardees collectively represents decades of commitment to improving the care and quality of life for people living with cancer," said Richard L. Schilsky, M.D., ASCO's Immediate Past President and Chair of the Special Awards Selection Committee. "Our understanding of the biological basis of cancer and our ability to transform that knowledge into better treatments for patients have been enhanced by their contributions and it is an honor to present them ASCO's highest awards."

The David A. Karnofsky Memorial Award was first presented in 1970. It recognizes outstanding contributions to cancer research, diagnosis and/or treatment. A lecture is given during the opening session of the ASCO Annual Meeting.

The award is named after David A. Karnofsky, 1914-1969, an American clinical oncologist and specialist in cancer chemotherapy who was affiliated with the Memorial Sloan-Kettering Cancer Center. He is known for developing the Karnofsky scale, an index for determining a patient's suitability for therapy and for estimating a patient's physical state, performance and prognosis after a therapeutic procedure.


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related medicine news :

1. Daniel Simon, MD Urges People with Diabetes to Protect Sight by Getting Diabetic Eye Exam
2. Dr. Daniel Von Hoff named honoree of Scottsdale Healthcare Foundation Honor Ball
3. Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009
4. Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure
5. Veteran Journalist Daniel Weintraub Launches HealthyCal.org
6. Pennsylvania EPA Awards Abington Memorial Hospital Funding for Green Projects
7. Carol Milgard Breast Center Awarded Highest Government Rating for Mammography Sites
8. Michael J. Fox Foundation Awards $2.8 Million to Drive Development of Parkinsons Disease Biomarker Pipeline
9. New Orleans Saints Offensive Line Honored with First Madden Most Valuable Protectors Award Presented by Prilosec OTC(R)
10. Frost & Sullivan Ghanaian Pharmaceutical Industry Innovation & Advancement Award Conferred on LaGray Chemical Company
11. UNFPA Honoured With Human Rights Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... ... (ONS) wanted to create a communications platform that positions them as the go-to ... and ONS reinvented their online publication as an always-on, always-fresh news, views and ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health (“GH”) ( ... patients for colonoscopy at the HyGIeaCare® Center that is to be located adjacent ... , The HyGIeaCare® Prep, cleared by the U.S. Food and Drug Administration ...
(Date:3/24/2017)... ... , ... “Vintage and Harvest A Cultivation of Christian Love” is the creation ... North Carolina with his wife, Anna Marie. He and his wife are the proud ... also the author of “Shadow and Substance.” , “Love, the agape kind, is seen ...
(Date:3/23/2017)... , ... March 23, 2017 , ... The physicians of ... in the greater Houston Area. The new location is located at 2255 E. Mossy ... in Springwoods Village. This newest location will provide patients living in the north Houston ...
(Date:3/23/2017)... ... ... The MBI “Hall of Fame” recognizes the contributions of those whose careers are or were ... careers of all others involved. , On Monday, March 21st, 2017 Laurie Robert, ... Fame. The induction took place during the World of Modular – Award Gala in ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Strategic Business Report" report to their offering. ... The report provides separate comprehensive analytics for the ... Europe , Asia-Pacific , Latin ... provided for the period 2015 through 2022. Also, a six-year historic analysis ...
(Date:3/24/2017)... -- HealthMine surveys with 9,250 insured consumers fielded from February ... want help from their plans in five key areas: ... 2) help closing gaps in care, 3) better digital ... relevant, real-time guidance. Meeting these needs is essential to ... A Reason to Stay Engaged in Health ...
(Date:3/24/2017)... and GENEVA , March 24, ... World Tuberculosis Day revitalizes efforts to develop sutezolid as ... On World Tuberculosis Day, TB Alliance and the Medicines ... clinical development of sutezolid, an antibiotic drug candidate which ... to the development of sutezolid in combination with other ...
Breaking Medicine Technology: